More Food & Drug Administration (FDA) Articles

Artificial Intelligence

FDA Completes Landmark AI Review Pilot, Sets Ambitious Rollout

The FDA’s landmark AI-assisted scientific review pilot signals a transformative shift under Chief AI Officer Jeremy Walsh. What might exploratory discussions with OpenAI mean for regulatory oversight and transparency? #FDA #AI #RegulatoryInnovation #OpenAI

Read More

Food & Drug Administration (FDA)

In House Warrior: Vaccine Mandates & The Return to Office Dilemma

Lowell Pearson, office managing partner, and Natalie Holden, associate, with Hush Blackwell in Jefferson City, Missouri join host Richard Levick to discuss the challenging issues facing a return to the office, including employers’ ability to mandate vaccines, the landscape of state legislation and executive orders, what FDA approving of the vaccine would mean and the trend of early vaccine mandate lawsuits.

Read More

Food & Drug Administration (FDA)

Vaccines: Where are We?

As the U.S. marches on with the two approved COVID-19 vaccines, it seems that the original plan to vaccinate 20 million people by the end of 2020 fell a little short. McNees Wallace & Nurick associate, Langdon Ramsburg, assesses where the situation stands and what comes next.

Read More